Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.
Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988.
Pharmaceutics. 2023.
PMID: 37514174
Free PMC article.
Head to head comparison performance of 99mTc-EDDA/HYNIC-iPSMA SPECT/CT and 68Ga-PSMA-11 PET/CT a prospective study in biochemical recurrence prostate cancer patients.
García-Pérez FO, Davanzo J, López-Buenrostro S, Santos-Cuevas C, Ferro-Flores G, Jímenez-Ríos MA, Scavuzzo A, Santana-Ríos Z, Medina-Ornelas S.
García-Pérez FO, et al. Among authors: lopez buenrostro s.
Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):332-340. eCollection 2018.
Am J Nucl Med Mol Imaging. 2018.
PMID: 30510850
Free PMC article.
Item in Clipboard
Cite
Cite